Laboratory Corporation of America — Federal Contractor Profile
Laboratory Corporation of America: $502M in Federal Contracts with Diverse Client Base
Contractor Overview
Total Contract Value: $501,958,431 ($502.0M)
Total Awards: 58
Company Profile
Laboratory Corporation of America (LabCorp) is a leading health care company that specializes in clinical laboratory testing and medical diagnostic services. The company's core capabilities include a wide range of diagnostic tests, from routine blood work to complex genetic analyses. LabCorp's extensive network of laboratories and partnerships with healthcare providers enable it to serve a broad spectrum of clients, from individual patients to large government agencies. LabCorp's government business is significant, with a total contract value of $502 million over 58 contracts, indicating a substantial presence in federal health care and research initiatives. However, the company has not won any new contracts recently, which could signal a potential shift in its business strategy or challenges in securing new government work. LabCorp's contract patterns reveal a diversified client base, with no single agency accounting for a majority of its government business. This suggests a balanced approach to government contracting, but also raises questions about the sustainability of its current strategy in the face of potential shifts in government priorities and funding. Compared to industry peers, LabCorp is a dominant player in the clinical laboratory testing market, with a strong track record of performance and a diverse portfolio of services. Its ability to adapt to changing market conditions and maintain a robust network of partnerships is a key factor in its continued success. Looking ahead, LabCorp's trajectory is likely to be shaped by its ability to innovate and respond to evolving healthcare needs, as well as its capacity to navigate the complex landscape of government contracting.
Specializations
- Clinical Laboratory Testing
- Genetic Analysis
- Pathology Services
- Pharmacy Services
- Point-of-Care Testing
- Specialized Diagnostics
- Public Health Surveillance
- Research Services
- Telemedicine Solutions
- Health Informatics
Contractor Metrics
Average Contract Size: $0
Competitive Win Rate: 100% (all contracts are competitive)
Agency Concentration: moderate
Growth Trajectory: stable
Sole Source Rate: 0%
Recompete Rate: 63.1% (37 out of 58 contracts are recompete/renewal)
Competitive Position
Laboratory Corporation of America is a dominant player in the clinical laboratory testing market, with a strong track record of performance and a diverse portfolio of services. The company's ability to adapt to changing market conditions and maintain a robust network of partnerships is a key factor in its continued success. LabCorp's competitive edge lies in its extensive network of laboratories, advanced diagnostic technologies, and comprehensive suite of services, which allow it to meet the diverse needs of its clients, including government agencies. While LabCorp is a major player, it faces competition from other large diagnostic companies and smaller niche providers, but its size and scale give it a significant advantage in securing government contracts.
Value to Taxpayers
Laboratory Corporation of America provides good value for taxpayer money through its extensive network of laboratories and advanced diagnostic technologies. The company's diverse portfolio of services, including specialized diagnostics and public health surveillance, ensures that it can meet the varied needs of government agencies. However, the lack of recent competitive wins and the high recompete rate suggest that LabCorp may be facing challenges in securing new contracts, which could impact its ability to maintain its current level of government business. The company's track record of performance and strong network of partnerships is a positive indicator of its value to taxpayers, but ongoing scrutiny is necessary to ensure that it continues to deliver high-quality services at competitive rates.
Agency Relationships
Laboratory Corporation of America has a diverse client base among government agencies, with no single agency accounting for a majority of its government business. This suggests a balanced approach to government contracting, but also raises questions about the sustainability of its current strategy in the face of potential shifts in government priorities and funding. While LabCorp's diversified client base reduces dependency on any single agency, the lack of recent competitive wins and the high recompete rate could indicate a concentration of business with certain agencies, which could pose risks if those agencies' priorities or funding change.
Red Flags
- No recent competitive wins: LabCorp has not secured any new contracts recently, which could indicate challenges in securing new government work.
- High recompete rate: 63.1% of LabCorp's contracts are recompete/renewal, suggesting a reliance on existing relationships rather than new business.
- Lack of sole-source awards: LabCorp has not won any sole-source contracts, which could indicate a competitive disadvantage in certain areas.
Green Flags
- Diverse client base: LabCorp's contracts are spread across multiple agencies, reducing dependency on any single client.
- Strong performance history: The company has a track record of delivering high-quality services and maintaining strong partnerships.
- Comprehensive service portfolio: LabCorp offers a wide range of diagnostic services, from routine blood work to specialized genetic analyses, which allows it to meet the diverse needs of its clients.
Key Contracts
Laboratory Corporation of America's most significant contracts include those with the Department of Defense (DoD) and the Department of Health and Human Services (HHS). These contracts involve providing a wide range of diagnostic services, from routine blood work to specialized genetic analyses, to support military and public health initiatives. For example, LabCorp has a contract with the DoD to provide laboratory services for military personnel and their families, which includes testing for infectious diseases, genetic disorders, and other health conditions. Similarly, LabCorp has a contract with HHS to provide diagnostic services for public health surveillance and research, which includes testing for emerging infectious diseases and other public health threats. These contracts reveal LabCorp's capabilities in providing comprehensive diagnostic services and its strategic focus on supporting government health initiatives. They also highlight the company's ability to adapt to changing market conditions and maintain strong partnerships with government agencies, which is a key factor in its continued success in the federal contracting market.
Frequently Asked Questions
What does Laboratory Corporation of America do for the federal government?
Laboratory Corporation of America (LabCorp) provides a wide range of diagnostic services, including clinical laboratory testing, genetic analysis, and specialized diagnostics, to support government health initiatives. The company's services are used to support military and public health programs, as well as research and surveillance efforts. LabCorp's extensive network of laboratories and partnerships with healthcare providers enable it to serve a broad spectrum of clients, from individual patients to large government agencies.
How much taxpayer money does Laboratory Corporation of America receive?
Laboratory Corporation of America has received a total of $502 million in federal contracts over 58 contracts, with an average contract size of $8,654,456. The company has not won any new contracts recently, which could signal a potential shift in its business strategy or challenges in securing new government work.
Is Laboratory Corporation of America good value for taxpayer money?
Laboratory Corporation of America provides good value for taxpayer money through its extensive network of laboratories and advanced diagnostic technologies. The company's diverse portfolio of services, including specialized diagnostics and public health surveillance, ensures that it can meet the varied needs of government agencies. However, the lack of recent competitive wins and the high recompete rate suggest that LabCorp may be facing challenges in securing new contracts, which could impact its ability to maintain its current level of government business. The company's track record of performance and strong network of partnerships is a positive indicator of its value to taxpayers, but ongoing scrutiny is necessary to ensure that it continues to deliver high-quality services at competitive rates.
How does Laboratory Corporation of America win its contracts?
Laboratory Corporation of America primarily wins its contracts through competitive bidding processes. The company has not won any sole-source contracts, which suggests that it faces competition from other large diagnostic companies and smaller niche providers. However, LabCorp's extensive network of laboratories, advanced diagnostic technologies, and comprehensive suite of services give it a significant advantage in securing government contracts. The company's strong performance history and ability to adapt to changing market conditions are also key factors in its success.
What agencies use Laboratory Corporation of America most?
Laboratory Corporation of America has a diverse client base among government agencies, with no single agency accounting for a majority of its government business. The company's contracts are spread across multiple agencies, including the Department of Defense (DoD), the Department of Health and Human Services (HHS), and others. This suggests a balanced approach to government contracting, but also raises questions about the sustainability of its current strategy in the face of potential shifts in government priorities and funding. While LabCorp's diversified client base reduces dependency on any single client, the lack of recent competitive wins and the high recompete rate could indicate a concentration of business with certain agencies, which could pose risks if those agencies' priorities or funding change.
What are the risks of relying on Laboratory Corporation of America?
The risks of relying on Laboratory Corporation of America include the lack of recent competitive wins and the high recompete rate, which could indicate challenges in securing new government work. The company's diversified client base reduces dependency on any single agency, but the concentration of business with certain agencies could pose risks if those agencies' priorities or funding change. Additionally, the lack of sole-source awards suggests a competitive disadvantage in certain areas, which could impact the company's ability to maintain its current level of government business. However, LabCorp's strong performance history and comprehensive service portfolio are positive indicators of its value to taxpayers, and ongoing scrutiny is necessary to ensure that it continues to deliver high-quality services at competitive rates.
How does Laboratory Corporation of America compare to similar contractors?
Laboratory Corporation of America is a dominant player in the clinical laboratory testing market, with a strong track record of performance and a diverse portfolio of services. The company's ability to adapt to changing market conditions and maintain a robust network of partnerships is a key factor in its continued success. While LabCorp faces competition from other large diagnostic companies and smaller niche providers, its size and scale give it a significant advantage in securing government contracts. However, ongoing scrutiny is necessary to ensure that it continues to deliver high-quality services at competitive rates and maintains its position as a leading provider of diagnostic services in the federal contracting market.
Recent Federal Contracts
Laboratory Corporation of America has 17 federal contracts on record. Below are the largest awards: